359821-14-0

Basic information

• Product Name: methyl (2S)-2-{[(benzyloxy)carbonyl]amino}-6-[methyl(trifluoroacetyl)amino]hexanoate
• Synonyms: methyl (2S)-2-{[(benzyloxy)carbonyl]amino}-6-[methyl(trifluoroacetyl)amino]hexanoate
• CAS NO: 359821-14-0
• Molecular Weight: 404.386
• Mol File: 359821-14-0.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: methyl (2S)-2-{[(benzyloxy)carbonyl]amino}-6-[methyl(trifluoroacetyl)amino]hexanoate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl (2S)-2-{[(benzyloxy)carbonyl]amino}-6-[methyl(trifluoroacetyl)amino]hexanoate(359821-14-0)
• EPA Substance Registry System: methyl (2S)-2-{[(benzyloxy)carbonyl]amino}-6-[methyl(trifluoroacetyl)amino]hexanoate(359821-14-0)

Safety Data

• Hazardous Substances Data: 359821-14-0(Hazardous Substances Data)

Upstream product

• 14905-30-7 (2S)-2-{[(benzyloxy)carbonyl]amino}-6-[(trifluoroacetyl)amino]hexanoic acid 
• 74-88-4 methyl iodide 

Downstream Products

• 1001647-16-0 N-α-carbenzoxy-N-ε-methyl-L-lysine 
• 191407-52-0 (2S,3R)-2-{3-[((S)-5-Benzyloxycarbonylamino-5-methoxycarbonyl-pentyl)-methyl-carbamoyloxy]-propyl}-3-isobutyl-succinic acid 4-benzyl ester 1-tert-butyl ester 
• 191407-58-6 (8S,11R,12S)-11-Isobutyl-3-methyl-2,10-dioxo-1-oxa-3,9-diaza-cyclopentadecane-8,12-dicarboxylic acid 12-(benzyloxy-amide) 8-methylamide 
• 191407-56-4 (8S,11R,12S)-12-Benzyloxycarbamoyl-11-isobutyl-3-methyl-2,10-dioxo-1-oxa-3,9-diaza-cyclopentadecane-8-carboxylic acid methyl ester 
• 191407-57-5 (8S,11R,12S)-12-Benzyloxycarbamoyl-11-isobutyl-3-methyl-2,10-dioxo-1-oxa-3,9-diaza-cyclopentadecane-8-carboxylic acid 
• 359821-15-1 methyl (2S)-2-{[(benzyloxy)carbonyl]amino}-6-(methylamino)hexanoate 

Relevant articles and documents

ALYSINE MONOMETHYLATED DERIVATIVE AND CORRESPONDING ANTIBODY AND USE THEREOF

Provided are artificially synthesized modified mono-methylated lysines and modified mono-methylated lysine derivatized polypeptides. Also provided is an antibody produced by using this modified mono-methylated lysine and modified mono-methylated lysine derivatized polypeptide as an antigen, the antibody can be used in recognizing and enriching the modified polypeptide after the lysine mono-methylated polypeptide being derivatized in vitro. Also provided are a preparation method of said antibody, a method for identifying and quantifying the lysine mono-methylated modified substrate in cell or tissue by using proteomics approach of affinity enrichment for specific antibody and mass spectrometry.